Literature DB >> 1992675

Cancer by industry: analysis of a population-based cancer registry with an emphasis on blue-collar workers.

N E Hall1, K D Rosenman.   

Abstract

This paper uses information on occupation and industry routinely collected in a state-based cancer registry to assess potential associations between work place exposures and cancer incidence. Industry-specific proportional cancer incidence ratios (PCIR) were calculated by race and sex for all individuals and for white males with blue-collar occupations. Expected numbers of cancers were derived both from cancers occurring among all occupations and just among blue-collar occupations. This latter analysis was done as a control for differences in the prevalence of life-style habits between blue- and white-collar workers. Increased lung cancer PCIR were seen in most industries previously reported to be associated with lung cancer risk. The effects of socioeconomic status on these results are discussed. Other results include an increased ratio of melanoma in blue-collar white male rubber and plastic product workers, an increased ratio of non-Hodgkin's lymphomas in motor vehicle manufacture workers, and an increased PCIR of chronic lymphocytic leukemia in general construction workers. Uterine cancer was increased in proportion in white females for a number of industries including rubber and plastic product manufacture, apparel manufacture, and electrical equipment manufacture.

Entities:  

Mesh:

Year:  1991        PMID: 1992675     DOI: 10.1002/ajim.4700190203

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  16 in total

Review 1.  Risk of bladder cancer in foundry workers: a meta-analysis.

Authors:  R R W Gaertner; G P Thériault
Journal:  Occup Environ Med       Date:  2002-10       Impact factor: 4.402

Review 2.  Occupational risk factors for female breast cancer: a review.

Authors:  M S Goldberg; F Labrèche
Journal:  Occup Environ Med       Date:  1996-03       Impact factor: 4.402

3.  Urinary malondialdehyde and 8-hydroxydeoxyguanosine as potential markers of oxidative stress in industrial art glass workers.

Authors:  C Tagesson; M Källberg; G Wingren
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

4.  Stomach cancer and occupation in Sweden: 1971-89.

Authors:  N Aragonés; M Pollán; P Gustavsson
Journal:  Occup Environ Med       Date:  2002-05       Impact factor: 4.402

5.  Incidence of cancer among bookbinders, printers, photoengravers, and typesetters.

Authors:  V Rafnsson
Journal:  Occup Environ Med       Date:  2001-08       Impact factor: 4.402

6.  Melanoma and occupation: results of a case-control study.

Authors:  L Fritschi; J Siemiatycki
Journal:  Occup Environ Med       Date:  1996-03       Impact factor: 4.402

Review 7.  Cancer risk in the rubber industry: a review of the recent epidemiological evidence.

Authors:  M Kogevinas; M Sala; P Boffetta; N Kazerouni; H Kromhout; S Hoar-Zahm
Journal:  Occup Environ Med       Date:  1998-01       Impact factor: 4.402

8.  Generational risks for cancers not related to tobacco, screening, or treatment in the United States.

Authors:  Yueh-Ying Han; Devra L Davis; Joel L Weissfeld; Gregg E Dinse
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

9.  Melanoma and occupation: results of a case-control study in The Netherlands.

Authors:  P J Nelemans; R Scholte; H Groenendal; L A Kiemeney; F H Rampen; D J Ruiter; A L Verbeek
Journal:  Br J Ind Med       Date:  1993-07

10.  INTEROCC case-control study: lack of association between glioma tumors and occupational exposure to selected combustion products, dusts and other chemical agents.

Authors:  Aude Lacourt; Elisabeth Cardis; Javier Pintos; Lesley Richardson; Laurel Kincl; Geza Benke; Sarah Fleming; Martine Hours; Daniel Krewski; Dave McLean; Marie-Elise Parent; Siegal Sadetzki; Klaus Schlaefer; Brigitte Schlehofer; Jerome Lavoue; Martie van Tongeren; Jack Siemiatycki
Journal:  BMC Public Health       Date:  2013-04-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.